Harlequin is a CBD-rich strain whose popularity predated the recent wave of non-psychoactive medical CBD strains like Charlotte’s Web. Harlequin is the sativa-dominant product of several different landrace strains: 1970s favorite Colombian Gold, Thai and Swiss sativa landraces, and a Nepali indica variety. These patchwork genetics may account for the strain’s name — “harlequin” originally referred to the brightly-patterned costumes of traditional Italian clowns of the same name. Harlequin is approximately 75% sativa, although it lacks the characteristically strong cerebral sativa high due to the mitigating presence of CBD. The standard ratio of CBD to THC in Harlequin is 5:2. Cannabis lab Analytics 360 has measured samples of this strain at between 4% to 10% THC and 6% to 15% CBD. Harlequin has won multiple Cannabis Cup awards for its CBD content in both bud and concentrate form.
Harlequin has tight, dense buds of medium size. Its leaves are medium green with pistils that vary in color from orange to vivid red. Despite lower than average concentrations of THC, Harlequin is typically covered in sticky white trichomes. When properly cured, the buds smell musky with traces of tropical fruit underneath. The combusted flowers have a woody, earthy scent and taste of mango and citrus fruits when inhaled. The smooth smoke is not known to induce coughing, and it finishes with a rich, hashy aftertaste.
Because its THC content is so low, and because its high CBD counteracts the psychoactive effects of that THC, Harlequin is not likely to get the user particularly high. Any mental effects take the form of an uplift in mood, conferring a mellow mindset and allowing for some mild anxiety relief. Some users report an increased sense of focus or a shift in perspective, but just as frequently, they’re able to pull themselves out of this altered state and closer to sobriety.